Strategic Focus Target a venture-backed, early-stage medical device company with a niche hydrosurf materials platform and first-in-human knee implant programs to expand adoption of HYALEX technology in joint preservation.

Clinical Momentum Leverage ongoing and upcoming presentations at ICRS Congress and participation in private MedTech summit to align sales outreach with key opinion leaders and potential early adopters in cartilage regeneration and joint preservation.

Regulatory Readiness Position solutions around regulatory affairs and clinical trial support, highlighting existing leadership in clinical and regulatory affairs and readiness to navigate investigational device pathways for knee implants.

Financial Levers Align value proposition to a company with modest revenue scale but substantial funding and growth potential; propose phased adoption, risk-sharing models, and pilot programs to de-risk larger scale procurement.

Strategic Partnerships Explore collaboration opportunities with larger orthopedic players through Hyalex’s unique low friction, low wear HYALEX materials to augment or complement their product portfolios in knee preservation and joint care.